This article includes a list of references, but its sources remain unclear because it has insufficient inline citations. (March 2010) (Learn how and when to remove this template message)
BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher. BioMed Central publishes over 250 scientific journals. All BioMed Central journals are only published online. BioMed Central describes itself as the first and largest open access science publisher. It is owned by Springer Nature.
|Parent company||Springer Nature|
|Founder||Current Science Group|
|Headquarters location||London, WC1|
|Publication types||Scientific journals|
BioMed Central was founded in 2000 as part of the Current Science Group (now Science Navigation Group, SNG), a nursery of scientific publishing companies. SNG chairman Vitek Tracz developed the concept for the company after NIH director Harold Varmus's PubMed Central concept for open-access publishing was scaled back. The first director of the company was Jan Velterop. In 2002, the company introduced article processing charges, and these have since been the primary source of revenue.
The flagship journals produced by BioMed Central include Genome Biology (impact factor 14.08), Genome Medicine, BMC Medicine, and BMC Biology. It also produces the BMC journal series of 68 journals covering the fields of biology and medicine. Chemistry Central and the PhysMath Central series of journals are also produced by the company. Most of the other journals published by BioMed Central are owned and produced independently by societies and academic editorial boards, with BioMed Central providing the hosting, publishing platform and marketing.
All journals are published online; some of the flagship journals have in the past also been available as print subscriptions, such as Arthritis Research & Therapy. Publications in BioMed Central journals are, immediately upon publication, released under the Creative Commons "Attribution" license which grants permission to reuse publications and produce derivative work. The only exceptions to this (as of 2010) were the flagship journals, which reserved rights on review and commentary content; those articles were available to purchase on a subscription or on a pay-per-view basis, becoming freely available (but not fully open access) to all after six months; however, as of January 2015, "no subscription fees apply to these journals or to any articles published in them."
BMC journal seriesEdit
The BMC-series of journals is a collection of 68 online research journals published by BioMed Central. Like all other BioMed Central journals, they have a policy of open access to the research articles they publish. Between them, they cover all major subject areas within biology and medicine. Two of the journals, BMC Biology and BMC Medicine, have a broad scope, and aim to publish particularly significant research. A third journal, BMC Research Notes, publishes research from all areas of biology and medicine without making impact or interest criteria for publication, while BMC Proceedings publishes conference proceedings. The other 65 journals specialise on a particular subject area. Due to their free licensing, images from BMC journals can be reused in other places.
Other BMC journals come from a variety of sources, including those published of behalf of scientific societies. As of June, 2019, they include: 
The company also has hosted biomedical databases, including Current Controlled Trials, a database of clinical trials. The Biology Image Library and the Cases Database, a database of medical case reports, were closed in 2014. The company also provided hosting for institutional repositories of publications based on the DSpace platform under the brand Open Repository. The Open Repository activity was sold to Atmire in 2016.
- "Interview with Vitek Tracz: Essential for Science". Infotoday.com. Retrieved 2012-03-15.
- Quint, Barbara (7 January 2002). "BioMed Central Begins Charging Authors and Their Institutions for Article Publishing". Information Today. Retrieved 2018-02-01.
- Suber, Peter (2008-10-07). "Peter Suber, Open Access News". Earlham.edu. Retrieved 2012-03-15.
- "Yale Libraries Pull Out of BioMed Central Over Cost of Publication". The Chronicle of Higher Education. 2007-08-09. ISSN 0009-5982. Retrieved 2019-02-27.
- "HIFA Supporting Organisations". HIFA2015. Archived from the original on 2014-12-08.
- "8. Do BioMed Central journals have Impact Factors and are they citation tracked?". BioMed Central. Archived from the original on 2016-10-30. Retrieved 2018-01-08.
- "Access to articles". BioMed Central. Retrieved 2015-11-15.
- "The BMC-series journals". BioMed Central. Retrieved 11 September 2012.
- BioMedCentral Journals Accessed June 11, 2019
- "Current Controlled Trials - Clinical Trial Search. ISRCTN numbering scheme. Database of Clinical Trials". Controlled-trials.com. Retrieved 2012-03-15.
- "Home Page". Cases Database. Retrieved 2014-02-15.
- http://casesdatabase.com/, Notice of Closure, July, 2014, accessed 2015-04-06
- "Home". Open Repository. Retrieved 2012-03-15.
- "Atmire acquires Open Repository". Library Technology Guides. 2016-08-01.
This article's further reading may not follow Wikipedia's content policies or guidelines. Please improve this article by removing less relevant or redundant publications with the same point of view; or by incorporating the relevant publications into the body of the article through appropriate citations. (January 2015) (Learn how and when to remove this template message)